- Tsang CCS, Garuccio J, Dong X, Sim Y, Wang J. Effects of Star Ratings bonus payments on disparities in medication utilization issues. Exploratory Research in Clinical and Social Pharmacy. 2023;11:100323.
- Tsang CCS, Wang J. Addressing racial/ethnic disparities associated with Medicare Part D Star Ratings among population with Alzheimer’s disease and related dementia. Expert Review of Pharmacoeconomics and Outcomes Research. 2023 Aug 21 [Online ahead of print]. doi: 10.1080/14737167.2023.2245139
- Dong X, Tsang CCS, Browning JA, Sim Y, Wan JY, Chisholm-Burns MA, Dagogo-Jack S, Cushman WC, Wang J. Solving racial/ethnic disparities associated with Medicare Part D Star Ratings. Current Medical Research and Opinion. 2023;39(7):963–971.
- Tsang CCS, Zhang X, Barenie RE, Cernasev A, Miller NA, Wan JY, Tsao JW, Wang J. Disparities associated with Medicare Part D Star Ratings measures among patients with Alzheimer’s disease and related dementias. Medicine (Baltimore). 2023;102(18):e33641.
- Tsang CCS, Shih YCT, Dong X, Garuccio J, Browning J, Wan JY, Chisholm-Burns MA, Dagogo-Jack S, Cushman WC, Zeng R, Wang J. Cost-effectiveness of Medication Therapy Management program across racial/ethnic groups among Medicare beneficiaries. Value in Health. 2023;26(5):649–657.
- Garuccio J, Tsang CCS, Wan JY, Shih YCT, Chisholm-Burns MA, Dagogo-Jack S, Cushman WC, Dong X, Browning J, Zeng R, Wang J. Racial and ethnic disparities in the enrolment of Medicare Medication Therapy Management programs. Journal of Pharmaceutical Health Services Research. 2023;14(2):188–197.
- Tsang CCS, Sim Y, Christensen ML, Wang J. Effects of Part D Star Ratings on racial and ethnic disparities in health care costs. Exploratory Research in Clinical and Social Pharmacy. 2023;9:100250.
- Dong X, Tsang CCS, Browning JA, Garuccio J, Wan JY, Shih YCT, Chisholm-Burns MA, Dagogo-Jack S, Cushman WC, Wang J. Racial and ethnic disparities in Medicare Part D Medication Therapy Management services utilization. Exploratory Research in Clinical and Social Pharmacy. 2023;9:100222.
- Browning J, Tsang CCS, Zeng R, Dong X, Garuccio J, Wan JY, Chisholm-Burns MA, Finch CK, Tsao JW, Wang J. Racial/ethnic disparities in the enrollment of Medication Therapy Management programs among Medicare beneficiaries with Alzheimer’s disease and related dementias. Current Medical Research and Opinion. 2022;38(10):1715–1725.
- Chisholm-Burns MA, Spivey CA, Tsang CCS, Wang J. Racial and ethnic disparities due to Medicare Part D Star Ratings criteria among kidney transplant patients with diabetes, hypertension, and/or dyslipidemia. Journal of Managed Care and Specialty Pharmacy. 2022;28(6):688–699.
- Browning J, Tsang CCS, Dong X, Wan JY, Chisholm-Burns MA, Finch CK, Tsao JW, Liu C, Wang J. Effects of Medicare comprehensive medication review on racial/ethnic disparities in nonadherence to statin medications among patients with Alzheimer’s disease: an observational analysis. BMC Health Services Research. 2022;22(1):159.
- Browning J, Tsang CCS, Wan JY, Chisholm-Burns MA, Dagogo-Jack S, Cushman WC, Dong X, Wang J. Racial and ethnic disparities associated with the measure for drug-drug interactions among Medicare beneficiaries. Journal of the American Pharmacists Association (2003). 2022;62(1):142–149.
- Dong X, Tsang CCS, Zhao S, Wan J, Shih YCT, Chisholm-Burns MA, Dagogo-Jack S, Cushman W, Hines L, Wang J. Effects of the Medicare Part D comprehensive medication review on racial and ethnic disparities in medication adherence. American Health and Drug Benefits. 2021;14(3):101–109.
- Dong X, Tsang CCS, Kotian A, Zeng J, Tran M, Wang J. A comparison between the effects of drug costs and share of family income on drug costs in determining drug price. Medicine (Baltimore). 2021;100(31):e26877.
- Dong X, Tsang CCS, Wan JY, Shih YCT, Chisholm-Burns MA, Dagogo-Jack S, Cushman WC, Hines LE, Wang J. Exploring racial and ethnic disparities in medication adherence among Medicare comprehensive medication review recipients. Exploratory Research in Clinical and Social Pharmacy. 2021;3:100041.
- Dong X, Tsang CCS, Zhao S, Browning JA, Wan JY, Chisholm-Burns MA, Finch CK, Tsao JW, Hines LE, Wang J. Effects of Medicare Part D comprehensive medication review on medication adherence among patients with Alzheimer’s disease. Current Medical Research and Opinion. 2021;37(9):1581–1588.
- Tsang CCS, Wan JY, Chisholm-Burns MA, Li M, Dagogo-Jack S, Cushman WC, Hines LE, Wang J. Racial/ethnic disparities in measure calculations for Part D Star Ratings among Medicare beneficiaries with diabetes, hypertension, and/or hyperlipidemia. Research in Social and Administrative Pharmacy. 2021;17(8):1469–1477.
- Phelps GA, Qiao Y, Buckley MG, Wang J, Li MS, Bhuyan SS, Chisholm-Burns MA. Effects of the 2013 American College of Cardiology/American Heart Association guidelines on racial and ethnic disparities in statin treatment among diabetics. Research in Social and Administrative Pharmacy. 2020;16(4):544–552.
- Li M, Schulz R, Wang J, Lu ZK. Pharmacy students’ intentions to utilize pharmacoeconomics, pharmacoepidemiology, and health outcomes in future jobs. Currents in Pharmacy Teaching and Learning. 2019;11(10): 995–1001.
- Spivey CA, Qiao Y, Wang J, Shih YCT, Wan JY, Dagogo-Jack S, Cushman WC, Hines LE, Chisholm-Burns MA. Comparative effectiveness of Medication Therapy Management eligibility criteria across racial/ethnic groups. Journal of the American Geriatrics Society. 2019;67(3):581–587.
- Qiao Y, Spivey CA, Wang J, Shih YCT, Wan JY, Kuhle J, Dagogo-Jack S, Cushman WC, Chisholm-Burns M. Predictive value positive of MTM eligibility criteria under MMA and ACA in identifying individuals with medication utilization issues. Journal of Pharmaceutical Health Services Research. 2018;9(4):393–401.
- Qiao Y, Spivey CA, Wang J, Shih YCT, Wan JY, Kuhle J, Dagogo-Jack S, Cushman WC, Chisholm-Burns MA. Higher predictive value positive for MMA than ACA MTM eligibility criteria among racial and ethnic minorities: an observational study. Inquiry. 2018;55:46958018795749.
- Spivey CA, Wang J, Qiao Y, Shih YCT, Wan JY, Kuhle J, Dagogo-Jack S, Cushman WC, Chisholm-Burns M. Racial and ethnic disparities in meeting MTM eligibility criteria based on Star Ratings compared with the Medicare Modernization Act. Journal of Managed Care and Specialty Pharmacy. 2018;24(2):97–107.
- Lu D, Qiao Y, Johnson KC, Wang J. Racial and ethnic disparities in meeting MTM eligibility criteria among patients with asthma. Journal of Asthma. 2017;54(5):504–513.
- Wang J, Qiao Y, Spivey CA, Li C, Clark C, Deng Y, Liu F, Tillman J, Chisholm-Burns M. Disparity implications of proposed 2015 Medicare eligibility criteria for Medication Therapy Management services. Journal of Pharmaceutical Health Services Research. 2016;7(4):209–215.
- Jamison JJ, Wang J, Surbhi S, Adams S, Solomon D, Hohmeier KC, McDonough S, Eoff JC III. Impact of Medicare Part D on racial and ethnic minorities. Diversity and Equality in Health and Care. 2016;13(5):326–333.
- Wang J, Qiao Y, Shih YCT, Jarrett-Jamison J, Spivey CA, Wan JY, White-Means SI, Dagogo-Jack S, Cushman WC, Chisholm-Burns M. Potential health implications of Medication Therapy Management eligibility criteria in the Patient Protection and Affordable Care Act across racial and ethnic groups. Journal of Managed Care and Specialty Pharmacy. 2015;21(11):993–1003.
- Wang J, Shih YCT, Qin Y, Young T, Thomas Z, Spivey CA, Solomon DK, Chisholm-Burns M. Trends in Medicare Part D Medication Therapy Management eligibility criteria. American Health and Drug Benefits. 2015;8(5):247–255.
- Wang J, Qiao Y, Shih YCT, Jamison JJ, Spivey CA, Li L, Wan JY, White-Means SI, Dagogo-Jack S, Cushman WC, Chisholm-Burns M. Effects of Medicare Part D on disparity implications of Medication Therapy Management eligibility criteria. American Health and Drug Benefits. 2014;7(6):346–358.
- Wang J, Surbhi S, Zhang Z, Spivey CA, Chisholm-Burns M. Historical trend of racial and ethnic disparities in meeting Medicare Medication Therapy Management eligibility criteria in non-Medicare population. Research in Social and Administrative Pharmacy. 2014;10(6):904–917.
- Wang J, Qiao Y, Shih YCT, Spivey CA, Dagogo-Jack S, Wan JY, White-Means SI, Cushman WC, Chisholm-Burns MA. Potential effects of racial and ethnic disparities in meeting Medicare Medication Therapy Management eligibility criteria. Journal of Pharmaceutical Health Services Research. 2014;5(2):109–118.
- Wang J, Qiao Y, Shih YCT, Wan JY, White-Means SI, Dagogo-Jack S, Cushman WC. Potential health implications of racial and ethnic disparities in meeting MTM eligibility criteria. Research in Social and Administrative Pharmacy. 2014;10(1):106–125.
- Munshi KD, Shih YCT, Brown LM, Dagogo-Jack S, Wan JY, Wang J. Disparity implications of the Medicare MTM eligibility criteria: a literature review. Expert Review of Pharmacoeconomics and Outcomes Research. 2013;13(2):201–216.
- Wang J, Qiao Y. Historical trend of disparity implications of Medicare MTM eligibility criteria. Research in Social and Administrative Pharmacy. 2013;9(6):758–769.
- Wang J, Brown LM, Hong SH. Racial and ethnic disparities in meeting Part D MTM eligibility criteria among the non-Medicare population. Journal of the American Pharmacists Association. 2012;52(5):e87–e96.
- Wang J, Hong SH, Meng S, Brown LM. Pharmacists’ acceptable levels of compensation for MTM services: a conjoint analysis. Research in Social and Administrative Pharmacy. 2011;7(4):383–395.
- Wang J, Mullins CD, Brown LM, Shih YCT, Dagogo-Jack S, Hong SH, Cushman WC. Disparity implications of Medicare eligibility criteria for Medication Therapy Management services. Health Services Research. 2010;45(4):1061–1082.
| M | T | W | T | F | S | S |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | ||||
| 4 | 5 | 6 | 7 | 8 | 9 | 10 |
| 11 | 12 | 13 | 14 | 15 | 16 | 17 |
| 18 | 19 | 20 | 21 | 22 | 23 | 24 |
| 25 | 26 | 27 | 28 | 29 | 30 | |